"Age of Onset" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual.
| Descriptor ID |
D017668
|
| MeSH Number(s) |
N05.715.350.075.100 N06.850.490.250.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Age of Onset".
Below are MeSH descriptors whose meaning is more specific than "Age of Onset".
This graph shows the total number of publications written about "Age of Onset" by people in this website by year, and whether "Age of Onset" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 6 | 6 |
| 1996 | 0 | 5 | 5 |
| 1997 | 1 | 8 | 9 |
| 1998 | 0 | 7 | 7 |
| 1999 | 1 | 6 | 7 |
| 2000 | 2 | 13 | 15 |
| 2001 | 0 | 14 | 14 |
| 2002 | 0 | 8 | 8 |
| 2003 | 1 | 6 | 7 |
| 2004 | 0 | 10 | 10 |
| 2005 | 0 | 12 | 12 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 15 | 15 |
| 2008 | 1 | 10 | 11 |
| 2009 | 0 | 8 | 8 |
| 2010 | 0 | 7 | 7 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 9 | 9 |
| 2013 | 0 | 7 | 7 |
| 2014 | 0 | 6 | 6 |
| 2015 | 0 | 16 | 16 |
| 2016 | 1 | 3 | 4 |
| 2017 | 0 | 7 | 7 |
| 2018 | 1 | 9 | 10 |
| 2019 | 2 | 8 | 10 |
| 2020 | 0 | 11 | 11 |
| 2021 | 0 | 12 | 12 |
| 2024 | 1 | 6 | 7 |
| 2025 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Age of Onset" by people in Profiles.
-
Integration of functional genomics and statistical fine-mapping systematically characterizes adult-onset and childhood-onset asthma genetic associations. Genome Med. 2025 Apr 10; 17(1):35.
-
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts. Alzheimers Dement. 2025 Feb; 21(2):e14489.
-
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials. J Prev Alzheimers Dis. 2025 Apr; 12(4):100075.
-
Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach. Alzheimers Res Ther. 2025 Feb 06; 17(1):38.
-
Rethinking the rise of early-onset gastrointestinal cancers: a call to action. JNCI Cancer Spectr. 2025 Jan 03; 9(1).
-
Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI. Alzheimers Dement. 2025 Jan; 21(1):e14218.
-
Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS. Alzheimers Dement. 2025 Feb; 21(2):e14439.
-
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study. Arthritis Care Res (Hoboken). 2025 Apr; 77(4):504-512.
-
A familial subtype of gambling disorder. J Behav Addict. 2024 Oct 04; 13(3):761-767.
-
Evaluation of the genetic basis of familial-associated early-onset hematologic cancers in an ancestral/ethnically diverse population. Haematologica. 2024 07 01; 109(7):2085-2091.